Home Newsletters Hematopoiesis News Antagonism of Inhibitors of Apoptosis Proteins Reveals a Novel, Immune-Based Therapeutic Approach...

Antagonism of Inhibitors of Apoptosis Proteins Reveals a Novel, Immune-Based Therapeutic Approach for T-Cell Lymphoma

0
Researchers showed that tolinapant acted as an efficacious immunomodulatory molecule capable of inducing complete tumor regression in a syngeneic model of T cell lymphoma exclusively in the presence of an intact immune system.
[Blood Advances]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version